§ 12-101. Definitions
West's Annotated Code of MarylandHealth OccupationsEffective: October 1, 2023
Effective: October 1, 2023
MD Code, Health Occupations, § 12-101
§ 12-101. Definitions
(b) “Authorized prescriber” means any licensed dentist, licensed dental hygienist with prescriptive authority under § 4-206.4 of this article, licensed physician, licensed podiatrist, licensed veterinarian, advanced practice registered nurse with prescriptive authority under Title 8 of this article, licensed nurse anesthetist, or other individual authorized by law to prescribe prescription or nonprescription drugs or devices.
(d-1) “Compounded nonsterile preparations” means products compounded in accordance with USP 795.
(e) “Compounded sterile preparations” means biologics, diagnostics, drugs, nutrients, and radiopharmaceuticals that, under USP 797, must be compounded using aseptic techniques.
(f)(1) “Compounding” means the preparation, mixing, assembling, packaging, or labeling of a drug or device:
(g)(1) “Delegated pharmacy act” means an activity that constitutes the practice of pharmacy delegated by a licensed pharmacist under this title and regulations adopted by the Board.
(i) “Direct supervision” means that a licensed pharmacist is physically available, notwithstanding appropriate breaks, on-site and in the prescription area or in an area where pharmacy services are provided to supervise the practice of pharmacy and delegated pharmacy acts.
(j) “Dispense” or “dispensing” means the procedure which results in the receipt of a prescription or nonprescription drug or device by a patient or the patient's agent and which entails the:
(k)(1) “Distribute” means the process resulting in the provision of a prescription or nonprescription drug or device to a separate, intervening individual, licensed and practicing under this article, prior to administration of the provided drug or device to the patient pursuant to a prescription issued by an authorized prescriber.
(l-1) “Injectable medication for treatment of a sexually transmitted infection” means a medication that:
(m) “Interchangeable biological product” means a biological product that is:
(n) “License” means, unless the context requires otherwise, a license issued to a pharmacist by the Board to practice pharmacy.
(o) “Licensed pharmacist” means, unless the context requires otherwise, a pharmacist who is licensed by the Board to practice pharmacy.
(o-1)(1) “Maintenance injectable medication” means a medication that:
(o-2) “Nicotine replacement therapy medication” means a drug or product, regardless of whether it is available over the counter, that:
(p) “Nonprescription drug” means a drug which may be sold without a prescription and which is labeled for use by the consumer in accordance with the requirements of the laws and regulations of this State and the federal government.
(q) “Nonresident pharmacy” means a pharmacy located outside this State that, in the normal course of business, as determined by the Board, ships, mails, or delivers drugs or devices to a person in this State pursuant to a prescription.
(r) “Pharmaceutical care” means the provision of a patient's drug regimen for the purpose of achieving definite outcomes related to the cure or prevention of a disease, elimination or reduction of a patient's symptoms, or arresting or slowing of a disease process by identifying, resolving, or preventing actual or potential drug therapy problems and which may include patient counseling and providing information to licensed and certified health care providers.
(s) “Pharmacist” means an individual who practices pharmacy regardless of the location where the activities of practice are performed.
(t) “Pharmacy” means an establishment in which prescription or nonprescription drugs or devices are compounded, dispensed, or distributed.
(u) “Pharmacy permit” means a permit issued by the Board to establish and operate a pharmacy.
(v) “Pharmacy student” means an individual who is enrolled as a student in a school or college of pharmacy approved by the Board or accredited by the Accreditation Council for Pharmacy Education.
(w) “Pharmacy technician trainee” means an individual engaged in a Board approved pharmacy technician training program.
(x)(1) “Practice pharmacy” means to engage in any of the following activities:
(y) “Registered pharmacy intern” means an individual who is registered with the Board to practice pharmacy under the direct supervision of a pharmacist.
(z) “Registered pharmacy technician” means an individual who is registered with the Board to perform delegated pharmacy acts.
(z-1) “Registration” means, unless the context requires otherwise, a registration issued by the Board to perform delegated pharmacy acts under the supervision of a licensed pharmacist.
(z-2)(1) “Self-administered drug” means a drug that is regularly administered by the patient for whom the drug is prescribed or by an individual who is not otherwise authorized to administer drugs under this article.
(aa) “Supervision” means reviewing the work, guiding and directing the activities, and monitoring the performance of an individual.
(cc) “USP 795” means the standards set forth in the United States Pharmacopeia, General Chapter 795, “Pharmaceutical Compounding--Nonsterile Preparations”.
Credits
Added by Acts 1981, c. 8, § 2, eff. July 1, 1981. Amended by Acts 1981, c. 182, § 1, eff. July 1, 1981; Acts 1990, c. 6, § 11, eff. Feb. 16, 1990; Acts 1990, c. 283, § 1, eff. May 2, 1990; Acts 1990, c. 352, § 1, eff. July 1, 1990; Acts 1991, c. 55, § 1, eff. April 9, 1991; Acts 1997, c. 614, § 1, eff. Oct. 1, 1997; Acts 2000, c. 61, § 7, eff. April 25, 2000; Acts 2002, c. 157, § 2, eff. July 1, 2002; Acts 2002, c. 249, § 1, eff. Oct. 1, 2002; Acts 2004, c. 339, § 1, eff. Oct. 1, 2004; Acts 2006, c. 523, § 1, eff. July 1, 2006; Acts 2009, c. 60, §§ 1, 5, eff. April 14, 2009; Acts 2009, c. 304, § 1, eff. Oct. 1, 2009; Acts 2009, c. 314, § 1, eff. Oct. 1, 2009; Acts 2009, c. 315, § 1, eff. Oct. 1, 2009; Acts 2010, c. 72, § 1, eff. April 13, 2010; Acts 2014, c. 564, § 1, eff. Oct. 1, 2014; Acts 2014, c. 565, § 1, eff. Oct. 1, 2014; Acts 2015, c. 5, §§ 1, 3, eff. April 14, 2015; Acts 2015, c. 22, § 5; Acts 2015, c. 447, § 1, eff. Oct. 1, 2015; Acts 2016, c. 687, § 1, eff. Oct. 1, 2016; Acts 2016, c. 688, § 1, eff. Oct. 1, 2016; Acts 2017, c. 62, § 6; Acts 2017, c. 726, § 2, eff. Oct. 1, 2017; Acts 2017, c. 764, § 1, eff. Oct. 1, 2017; Acts 2017, c. 820, § 1, eff. July 1, 2017; Acts 2017, c. 821, § 1, eff. July 1, 2017; Acts 2020, c. 311, § 1, eff. Oct. 1, 2020; Acts 2021, c. 757, § 1, eff. May 30, 2021; Acts 2021, c. 758, § 1, eff. May 30, 2021; Acts 2022, c. 319, § 1, eff. Oct. 1, 2022; Acts 2022, c. 320, § 1, eff. Oct. 1, 2022; Acts 2022, c. 686, § 1, eff. Oct. 1, 2022; Acts 2022, c. 719, § 1, eff. Oct. 1, 2022; Acts 2022, c. 720, § 1, eff. Oct. 1, 2022; Acts 2023, c. 218, § 1, eff. April 24, 2023; Acts 2023, c. 327, § 1, eff. Oct. 1, 2023; Acts 2023, c. 328, § 1, eff. Oct. 1, 2023.
MD Code, Health Occupations, § 12-101, MD HEALTH OCCUP § 12-101
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |